Wellington Shields Capital Management, LLC Amgen Inc Transaction History

Wellington Shields Capital Management, LLC

$1.23 Billion
Q4 2024

A detailed history of Wellington Shields Capital Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Wellington Shields Capital Management, LLC holds 237,480 shares of AMGN stock, worth $72 Million. This represents 5.03% of its overall portfolio holdings.

Number of Shares

237,480

Previous 3,801 6147.83%

Holding current value

$72 Million

Previous $1.22 Million 4956.86%

% of portfolio

5.03%

Previous 0.22%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$258.78 - $328.31 $60.5 Million - $76.7 Million	233,679 Added 6147.83%	237,480 $61.9 Million
Q3 2024 Nov 13, 2024	BUY	$309.38 - $337.38 $618 - $674	2 Added 0.05%	3,801 $1.22 Million
Q2 2024 Aug 05, 2024	BUY	$262.75 - $319.31 $26,800 - $32,569	102 Added 2.76%	3,799 $1.19 Million
Q1 2024 May 03, 2024	SELL	$268.87 - $324.56 $33,339 - $40,245	-124 Reduced 3.25%	3,697 $1.05 Million
Q4 2023 Feb 09, 2024	SELL	$255.7 - $288.46 $12,529 - $14,134	-49 Reduced 1.27%	3,821 $1.1 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $437 - $542	2 Added 0.05%	3,870 $1.04 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $64,066 - $75,757	-299 Reduced 7.18%	3,868 $858,000
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $21,901 - $26,694	-97 Reduced 2.27%	4,167 $1.01 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $229 - $291	1 Added 0.02%	4,264 $1.12 Million
Q3 2022 Nov 14, 2022	SELL	$224.46 - $253.15 $21,997 - $24,808	-98 Reduced 2.25%	4,263 $961,000
Q2 2022 Aug 12, 2022	SELL	$230.71 - $256.74 $20 Million - $22.2 Million	-86,523 Reduced 95.2%	4,361 $1.06 Million
Q1 2022 May 12, 2022	BUY	$219.27 - $242.57 $18.6 Million - $20.6 Million	84,728 Added 1376.35%	90,884 $1.14 Million
Q4 2021 Feb 15, 2022	BUY	$198.88 - $227.6 $1.22 Million - $1.4 Million	6,156 New	6,156 $1.39 Million
Q3 2021 Nov 10, 2021	SELL	$212.27 - $248.7 $1.55 Million - $1.82 Million	-7,300 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$233.58 - $259.14 $34.7 Million - $38.5 Million	-148,586 Reduced 95.32%	7,300 $1.78 Million
Q1 2021 May 12, 2021	BUY	$221.91 - $258.6 $33 Million - $38.4 Million	148,636 Added 2050.15%	155,886 $38.8 Million
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $1.35 Million - $1.61 Million	6,250 Added 625.0%	7,250 $1.67 Million
Q3 2020 Nov 10, 2020	SELL	$234.65 - $260.95 $1,407 - $1,565	-6 Reduced 0.6%	1,000 $254,000
Q2 2020 Aug 05, 2020	BUY	$197.81 - $242.74 $1,186 - $1,456	6 Added 0.6%	1,006 $237,000
Q4 2019 Feb 11, 2020	SELL	$189.21 - $243.2 $18,921 - $24,320	-100 Reduced 9.09%	1,000 $241,000
Q2 2019 Aug 08, 2019	BUY	$166.7 - $195.41 $183,370 - $214,951	1,100 New	1,100 $203,000
Q4 2018 Feb 11, 2019	SELL	$178.4 - $208.25 $173,940 - $203,043	-975 Closed	0 $0
Q3 2018 Nov 06, 2018	BUY	$185.29 - $208.89 $180,657 - $203,667	975 New	975 $202,000
Q2 2018 Aug 02, 2018	SELL	$166.05 - $186.51 $327,948 - $368,357	-1,975 Closed	0 $0
Q3 2017 Nov 06, 2017	BUY	$167.29 - $191.0 $330,397 - $377,225	1,975	1,975 $368,000

Others Institutions Holding AMGN

# of Institutions

3,164

Shares Held

418M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $162B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Shields Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Shields Capital Management, LLC with notifications on news.

Account

Wellington Shields Capital Management, LLC Amgen Inc Transaction History